4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-054221
Chief Medical Officer sold 6,250 shares at an average $49.20 ($307,518)
- Chief Medical Officer acquired 6,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BALDO LANCE · Chief Medical Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-06 | Exercise or conversion : show line 1 in the form | +6,250 | $7.80 | $48,750 | 6,250 | D |
| 2020-10-06 | Sale : show line 2 in the form | −4,236 | $48.90 | $207,140 | 2,014 | D |
| 2020-10-06 | Sale : show line 3 in the form | −2,014 | $49.84 | $100,378 | 0 | D |
| Open-market sales · 6,250 sh · avg $49.20 · $307,518 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-10-06 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −6,250 | 393,750 | D |
Loading xslF345X03/doc4.xml…